RT Journal Article
SR Electronic
T1 Listening to Bluetooth Beacons for Epidemic Risk Mitigation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.21.21250209
DO 10.1101/2021.01.21.21250209
A1 Gilles Barthe
A1 Roberta De Viti
A1 Peter Druschel
A1 Deepak Garg
A1 Manuel Gomez-Rodriguez
A1 Pierfrancesco Ingo
A1 Heiner Kremer
A1 Matthew Lentz
A1 Lars Lorch
A1 Aastha Mehta
A1 Bernhard Schölkopf
YR 2021
UL http://medrxiv.org/content/early/2021/03/24/2021.01.21.21250209.abstract
AB During the ongoing COVID-19 pandemic, there have been burgeoning efforts to develop and deploy digital contact tracing systems to expedite contact tracing and risk notification. Unfortunately, the success of these systems has been limited, partly owing to poor interoperability with manual contact tracing, low adoption rates, and a societally sensitive trade-off between utility and privacy. In this work, we introduce a new privacy-preserving and inclusive system for epidemic risk assessment and notification that aims to address the above limitations. Rather than capturing pairwise encounters between user devices as done by existing systems, our system captures encounters between user devices and beacons placed in strategic locations where infection clusters may originate. Epidemiological simulations using an agent-based model demonstrate several beneficial properties of our system. By achieving bidirectional interoperability with manual contact tracing, our system may help reduce the effective reproduction number already at adoption levels of 10%. The use of location and environmental information provided by beacons allows our system to achieve significantly higher sensitivity and specificity than existing systems and thus may improve the efficacy of contact tracing under limited isolation and testing resources. Moreover, to achieve high utility, it is sufficient to deploy beacons in a small fraction of strategic locations. Finally, our simulations also show that existing systems could inherit these beneficial properties if they integrated the beacons used by our system.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the data used in the study is publicly available and is anonymized.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode and data to reproduce our epidemiological simulations are available at https://github.com/covid19-model/simulator/tree/beacon. https://github.com/covid19-model/simulator/tree/beacon http://pancast.mpi-sws.org